Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+14.3%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$127M
Cap. Flow %
-0.79%
Top 10 Hldgs %
35.05%
Holding
1,426
New
92
Increased
658
Reduced
348
Closed
103

Sector Composition

1 Real Estate 52.11%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.83%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
APGE icon
1176
Apogee Therapeutics
APGE
$2.26B
$5K ﹤0.01%
+196
New +$5K
ARDX icon
1177
Ardelyx
ARDX
$1.57B
$5K ﹤0.01%
754
AUPH icon
1178
Aurinia Pharmaceuticals
AUPH
$1.63B
$5K ﹤0.01%
528
GMAB icon
1179
Genmab
GMAB
$16.9B
$5K ﹤0.01%
172
GRFS icon
1180
Grifois
GRFS
$6.89B
$5K ﹤0.01%
398
MRUS icon
1181
Merus
MRUS
$5.1B
$5K ﹤0.01%
186
RLAY icon
1182
Relay Therapeutics
RLAY
$710M
$5K ﹤0.01%
486
XNCR icon
1183
Xencor
XNCR
$610M
$5K ﹤0.01%
222
ZLAB icon
1184
Zai Lab
ZLAB
$3.42B
$5K ﹤0.01%
193
SAGE
1185
DELISTED
Sage Therapeutics
SAGE
$5K ﹤0.01%
239
SNDX icon
1186
Syndax Pharmaceuticals
SNDX
$1.47B
$5K ﹤0.01%
242
VIR icon
1187
Vir Biotechnology
VIR
$732M
$5K ﹤0.01%
535
VRNA
1188
Verona Pharma
VRNA
$9.2B
$5K ﹤0.01%
244
ALPN
1189
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$5K ﹤0.01%
238
+153
+180% +$3.21K
KROS icon
1190
Keros Therapeutics
KROS
$633M
$4K ﹤0.01%
111
LGND icon
1191
Ligand Pharmaceuticals
LGND
$3.25B
$4K ﹤0.01%
63
MIRM icon
1192
Mirum Pharmaceuticals
MIRM
$3.82B
$4K ﹤0.01%
148
MNKD icon
1193
MannKind Corp
MNKD
$1.7B
$4K ﹤0.01%
1,058
PLRX icon
1194
Pliant Therapeutics
PLRX
$114M
$4K ﹤0.01%
196
PRME icon
1195
Prime Medicine
PRME
$663M
$4K ﹤0.01%
+398
New +$4K
PTGX icon
1196
Protagonist Therapeutics
PTGX
$3.77B
$4K ﹤0.01%
163
SRRK icon
1197
Scholar Rock
SRRK
$3.02B
$4K ﹤0.01%
208
TNGX icon
1198
Tango Therapeutics
TNGX
$772M
$4K ﹤0.01%
355
MORF
1199
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4K ﹤0.01%
155
DCPH
1200
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
272